Shanghai OPM Biosciences Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,368	4,148	6,332	8,460	-	-
Market Cap Growth	44.55%	-34.49%	-25.16%	-	-	-
Enterprise Value	5,053	2,834	4,889	6,795	-	-
Last Close Price	48.97	36.14	53.89	71.16	-	-
PE Ratio	132.35	197.05	117.18	80.29	-	-
Forward PE	50.48	40.23	-	-	-	-
PS Ratio	17.94	13.96	26.04	28.74	-	-
PB Ratio	3.03	1.98	2.93	3.87	-	-
P/TBV Ratio	3.08	2.02	2.99	3.95	-	-
P/OCF Ratio	-	59.91	109.26	75.80	-	-
EV/Sales Ratio	14.24	9.53	20.11	23.08	-	-
EV/EBITDA Ratio	59.20	67.11	103.93	59.98	-	-
EV/EBIT Ratio	101.88	438.58	256.99	76.35	-	-
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.22	0.07
Debt / EBITDA Ratio	0.71	1.25	1.24	0.75	1.45	1.54
Debt / FCF Ratio	2.77	-	-	-	14.09	-
Net Debt / Equity Ratio	-0.62	-0.61	-0.65	-0.74	-0.41	-0.56
Net Debt / EBITDA Ratio	-18.14	-30.08	-30.06	-14.34	-3.08	-12.52
Net Debt / FCF Ratio	-61.91	24.61	72.18	45.98	-26.48	8.33
Asset Turnover	0.16	0.13	0.11	0.19	0.33	0.35
Inventory Turnover	2.48	2.63	2.18	2.76	3.72	4.81
Quick Ratio	15.13	12.18	22.37	20.18	4.09	9.41
Current Ratio	16.26	12.97	23.49	20.94	4.60	10.03
Return on Equity (ROE)	2.03%	0.95%	2.45%	7.67%	11.43%	4.08%
Return on Assets (ROA)	0.85%	0.18%	0.51%	3.60%	5.35%	1.14%
Return on Invested Capital (ROIC)	2.55%	0.46%	2.52%	17.58%	17.84%	4.02%
Return on Capital Employed (ROCE)	1.40%	0.30%	0.90%	3.90%	8.50%	1.30%
Earnings Yield	0.65%	0.51%	0.85%	1.24%	-	-
FCF Yield	-	-1.24%	-0.31%	-0.42%	-	-
Dividend Yield	0.86%	1.16%	0.82%	0.60%	-	-
Payout Ratio	-	243.29%	136.63%	1.97%	2.99%	18.32%
Buyback Yield / Dilution	-2.79%	-1.72%	-13.48%	-17.43%	-0.20%	-
Total Shareholder Return	-1.86%	-0.56%	-12.66%	-16.83%	-0.20%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.